Literature DB >> 10773193

Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.

H M Haughey1, J M Brown, D G Wilkins, G R Hanson, A E Fleckenstein.   

Abstract

It has been demonstrated that methamphetamine (METH) administration affects Na(+)/Cl(-)-dependent transporters; for example, METH treatment rapidly and reversibly decreases dopamine (DA) and serotonin (5HT) transporter function in rat striatum in vivo, as assessed in synaptosomes prepared from METH-treated rats. Because acute effects of METH on other transporters within this family have been less studied, the responses of norepinephrine (NE) and gamma-aminobutyric acid (GABA) transporters to METH administration(s) were determined. Both single and multiple METH administrations inhibited hippocampal NE uptake 1 h after METH treatment(s). In contrast, striatal GABA uptake was not affected by either treatment paradigm. The effects observed after both single and multiple METH administrations on NE transporters were attributable to increases in K(m,) with no changes in V(max); effects that were eliminated by repeated washing of the synaptosomes. These 'washout' data suggest that residual METH introduced by the in vivo subcutaneous injection(s) directly reduced NE transporter activity in the in vitro assay and that, unlike DA and 5HT transporters, METH did not indirectly alter NE transporter function. Taken together, these data demonstrate differences in the responses of NE, GABA, DA, and 5HT transporters to METH treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773193     DOI: 10.1016/s0006-8993(00)02094-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats.

Authors:  Aram Parsegian; Ronald E See
Journal:  Neuropsychopharmacology       Date:  2013-09-02       Impact factor: 7.853

2.  Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Katherine D Holland; Charles V Vorhees; Michael T Williams
Journal:  Open Neuropsychopharmacol J       Date:  2012

3.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

4.  Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.

Authors:  Samuel U Park; Jasmine V Ferrer; Jonathan A Javitch; Donald M Kuhn
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

5.  Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.

Authors:  Jennifer M Loftis; Dongseok Choi; William Hoffman; Marilyn S Huckans
Journal:  Neurotox Res       Date:  2010-10-17       Impact factor: 3.911

6.  Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.

Authors:  David M Thomas; Dina M Francescutti-Verbeem; Donald M Kuhn
Journal:  J Neurochem       Date:  2009-04-28       Impact factor: 5.372

Review 7.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Laura E Halpin; Stuart A Collins; Bryan K Yamamoto
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.